[TH="width: 35%"]Description[/TH] | |||
[TD="colspan: 5"][/TD] | |||
[TD="colspan: 6"] | Patient is Fasting[/TD] | ||
[TD="colspan: 6, align: left"]005009 - CBC With Differential/Platelet[/TD] | |||
WBC | [TD="align: center"]6.8[/TD] | ||
RBC | [TD="align: center"]4.88[/TD] | ||
Hemoglobin | [TD="align: center"]15.2[/TD] | ||
Hematocrit | [TD="align: center"]44.2[/TD] | ||
MCV | [TD="align: center"]91[/TD] | ||
MCH | [TD="align: center"]31.1[/TD] | ||
MCHC | [TD="align: center"]34.4[/TD] | ||
RDW | [TD="align: center"]13.6[/TD] | ||
Platelets | [TD="align: center"]268[/TD] | ||
Neutrophils | [TD="align: center"]54[/TD] | ||
Lymphs | [TD="align: center"]32[/TD] | ||
Monocytes | [TD="align: center"]9[/TD] | ||
Eos | [TD="align: center"]4[/TD] | ||
Basos | [TD="align: center"]1[/TD] | ||
Immature Cells | [TD="align: center"][/TD] | ||
Neutrophils (Absolute) | [TD="align: center"]3.6[/TD] | ||
Lymphs (Absolute) | [TD="align: center"]2.1[/TD] | ||
Monocytes(Absolute) | [TD="align: center"]0.6[/TD] | ||
Eos (Absolute) | [TD="align: center"]0.3[/TD] | ||
Baso (Absolute) | [TD="align: center"]0.1[/TD] | ||
Immature Granulocytes | [TD="align: center"]0[/TD] | ||
Immature Grans (Abs) | [TD="align: center"]0.0[/TD] | ||
NRBC | [TD="align: center"][/TD] | ||
Hematology Comments: | [TD="align: center"][/TD] | ||
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]322000 - Comp. Metabolic Panel (14)[/TD] | |||
Glucose, Serum | [TD="align: center"]104[/TD] | [TD="align: center"]mg/dL[/TD] | |
BUN | [TD="align: center"]19[/TD] | ||
Creatinine, Serum | [TD="align: center"]1.32[/TD] | [TD="align: center"]mg/dL[/TD] | |
eGFR If NonAfricn Am | [TD="align: center"]61[/TD] | ||
eGFR If Africn Am | [TD="align: center"]70[/TD] | ||
BUN/Creatinine Ratio | [TD="align: center"]14[/TD] | ||
Sodium, Serum | [TD="align: center"]141[/TD] | ||
Potassium, Serum | [TD="align: center"]4.2[/TD] | ||
Chloride, Serum | [TD="align: center"]100[/TD] | ||
Carbon Dioxide, Total | [TD="align: center"]28[/TD] | ||
Calcium, Serum | [TD="align: center"]9.2[/TD] | ||
Protein, Total, Serum | [TD="align: center"]6.2[/TD] | ||
Albumin, Serum | [TD="align: center"]4.3[/TD] | ||
Globulin, Total | [TD="align: center"]1.9[/TD] | ||
A/G Ratio | [TD="align: center"]2.3[/TD] | ||
Bilirubin, Total | [TD="align: center"]0.3[/TD] | ||
Alkaline Phosphatase, S | [TD="align: center"]68[/TD] | ||
AST (SGOT) | [TD="align: center"]29[/TD] | ||
ALT (SGPT) | [TD="align: center"]23[/TD] | ||
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]140103 - Testosterone,Free and Total[/TD] | |||
Testosterone, Serum | [TD="align: center"]1327[/TD] | [TD="align: center"]ng/dL[/TD] | |
Comment: | [TD="align: center"][/TD] | ||
[TD="colspan: 6"] | Adult male reference interval is based on a population of lean males[/TD] | ||
[TD="colspan: 6"] | up to 40 years old.[/TD] | ||
Free Testosterone(Direct) | [TD="align: center"]41.8[/TD] | [TD="align: center"]pg/mL[/TD] | |
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]004283 - Luteinizing Hormone(LH), S[/TD] | |||
LH | [TD="align: center"]0.1[/TD] | [TD="align: center"]mIU/mL[/TD] | |
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]004309 - FSH, Serum[/TD] | |||
FSH | [TD="align: center"]0.3[/TD] | [TD="align: center"]mIU/mL[/TD] | |
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]004515 - Estradiol[/TD] | |||
Estradiol | [TD="align: center"]17.7[/TD] | ||
[TD="colspan: 6"] | Roche ECLIA methodology[/TD] | ||
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]010322 - Prostate-Specific Ag, Serum[/TD] | |||
Prostate Specific Ag, Serum | [TD="align: center"]1.7[/TD] | ||
[TD="colspan: 6"] | Roche ECLIA methodology.[/TD] | ||
[TD="colspan: 6"] | .[/TD] | ||
[TD="colspan: 6"] | According to the American Urological Association, Serum PSA should[/TD] | ||
[TD="colspan: 6"] | decrease and remain at undetectable levels after radical[/TD] | ||
[TD="colspan: 6"] | prostatectomy. The AUA defines biochemical recurrence as an initial[/TD] | ||
[TD="colspan: 6"] | PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory[/TD] | ||
[TD="colspan: 6"] | PSA value 0.2 ng/mL or greater.[/TD] | ||
[TD="colspan: 6"] | Values obtained with different assay methods or kits cannot be used[/TD] | ||
[TD="colspan: 6"] | interchangeably. Results cannot be interpreted as absolute evidence[/TD] | ||
[TD="colspan: 6"] | of the presence or absence of malignant disease.[/TD] | ||
[TD="colspan: 6"][/TD] | |||
[TD="colspan: 6, align: left"]140244 - Estradiol, Sensitive[/TD] | |||
Estradiol, Sensitive | [TD="align: center"]6[/TD] | ||
[TD="colspan: 6"] | Male Female[/TD] | ||
[TD="colspan: 6"] | 0- 6 yrs. 0 - 15 0 - 15[/TD] | ||
[TD="colspan: 6"] | 7-10 yrs. 0 - 15 0 - 70[/TD] | ||
[TD="colspan: 6"] | 11-12 yrs. 0 - 40 10 - 300[/TD] | ||
[TD="colspan: 6"] | 13-15 yrs. 0 - 45 10 - 300[/TD] | ||
[TD="colspan: 6"] | >15 yrs. 3 - 70 See Below[/TD] | ||
[TD="colspan: 6"] | Ovulating Female[/TD] | ||
[TD="colspan: 6"] | Follicular Phase 9 - 175[/TD] | ||
[TD="colspan: 6"] | Luteal Phase 44 - 196[/TD] | ||
[TD="colspan: 6"] | Periovulatory 107 - 281[/TD] | ||
[TD="colspan: 6"] | Oral Contraceptives 0 - 91[/TD] | ||
[TD="colspan: 6"] | Postmenopausal[/TD] | ||
[TD="colspan: 6"] | Treated 42 - 289[/TD] | ||
[TD="colspan: 6"] | Untreated 0 - 19[/TD] | ||
[TD="colspan: 6"] | .[/TD] | ||
[TD="colspan: 6"] | Estradiol results obtained with different[/TD] | ||
[TD="colspan: 6"] | assay methods cannot be used interchangeably.[/TD] | ||
[TD="colspan: 6"] | It is recommended that only one assay method[/TD] | ||
[TD="colspan: 6"] | be used consistently to monitor serial[/TD] | ||
[TD="colspan: 6"] | patient results.[/TD] |